Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05517720 · ClinicalTrials.gov registry record · NA
An Exploratory Investigation of a Novel Skincare Regimen
A NA study of Acne and Wrinkle, sponsored by Trophy Skin.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05517720: Completed NA study of Acne and Wrinkle, sponsored by Trophy Skin.
NCT05517720 is a NA study of Acne and Wrinkle that has completed, run by Trophy Skin. The registered enrollment target is 38 participants, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05517720, a NA study of Acne and Wrinkle, has completed, sponsored by Trophy Skin.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.
Primary Outcome
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
Conditions Studied
Interventions
- OTHER Aria Trio complete Facial System
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-04-13 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT05517720 record still lists
NCT05517720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 141-participant average among 26 other Acne trials with a reported enrollment target (73% lower).
The record links to 4 conditions, with Acne appearing as the primary indexed condition, and to 1 intervention - of which Aria Trio complete Facial System is the first listed.
NCT05517720 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05517720 about?
NCT05517720 is a clinical study titled "An Exploratory Investigation of a Novel Skincare Regimen". This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will impro...
What is the current status of trial NCT05517720?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2022-04-13. Estimated completion is 2022-07-01.
What conditions does trial NCT05517720 study?
This clinical trial studies the following conditions: Acne, Wrinkle, Photoaging, Skin Inflammation.
What interventions are being tested in trial NCT05517720?
The interventions under investigation include: Aria Trio complete Facial System (OTHER).
Who is sponsoring clinical trial NCT05517720?
This trial is sponsored by Trophy Skin, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05517720 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05517720's enrollment target sits among peer trials
38 18th of 26 higher than 8 of 26 other Acne trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI